Elizabeth L Hougen sold $16.3M of Ionis Pharmaceuticals (IONS)

Executed Mar 16, disclosed Mar 18, 2 days later.

Value, as filed

$16.3M

225,220 sh across 3 lots

Executed

Mar 16

the trade date, as filed

Disclosed

Mar 18

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

EH Elizabeth L Hougen EVP, Finance & CFO profile →

Elizabeth L Hougen (EVP, Finance & CFO) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Ionis Pharmaceuticals, Inc. (IONS). The largest single filing was $16.3M of IONS (225,220 sh across 3 lots, as filed), executed Mar 16.

The name

IONS Ionis Pharmaceuticals, Inc. IONS · Healthcare · 119 filings in 24 months ticker →

Healthcare · Ionis Pharmaceuticals, Inc., a commercial-stage biotechnology company, provides RNA-targeted medicines in the United States

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Elizabeth L Hougen in IONS

IONSSALE Ionis Pharmaceuticals, Inc. $582K
6,988 sh × $83.24
Exec Jan 30
Filed Feb 2 · 5:30 PM ET IONSSALE Ionis Pharmaceuticals, Inc. $972K
12,922 sh × $75.22
Exec Jan 16
Filed Jan 20 · 5:30 PM ET IONSSALE Ionis Pharmaceuticals, Inc. $3.2M
49,800 sh × $65.26
Exec Sep 30 2025
Filed Oct 1 2025 · 5:30 PM ET IONSSALE Ionis Pharmaceuticals, Inc. $291K
8,870 sh × $32.81
Exec Jan 16 2025
Filed Jan 17 2025 · 5:30 PM ET